Revisiting the Utility of Dilated Fundus Exams in Patients with Neovascular Age-Related Macular Degeneration Receiving Regular Intravitreal Injections

Patients receiving regular anti-vascular endothelial growth factor (anti-VEGF) intravitreal injections for neovascular age-related macular degeneration (nAMD) routinely undergo dilated fundus examination (DFE) at each visit. In this paper, we review the current evidence on the utility of DFE in guid...

Descripción completa

Detalles Bibliográficos
Autores principales: Antaki, Fares, Milad, Daniel, Dirani, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967028/
https://www.ncbi.nlm.nih.gov/pubmed/33746511
http://dx.doi.org/10.2147/OPTH.S303551
_version_ 1783665787062452224
author Antaki, Fares
Milad, Daniel
Dirani, Ali
author_facet Antaki, Fares
Milad, Daniel
Dirani, Ali
author_sort Antaki, Fares
collection PubMed
description Patients receiving regular anti-vascular endothelial growth factor (anti-VEGF) intravitreal injections for neovascular age-related macular degeneration (nAMD) routinely undergo dilated fundus examination (DFE) at each visit. In this paper, we review the current evidence on the utility of DFE in guiding treatment of established patients with nAMD and discuss novel treatment algorithms that defer DFE assessments with the advent of optical coherence tomography (OCT). We also debate on the value of DFE in the current sanitary context of COVID-19 and highlight important clinical scenarios where it must be performed.
format Online
Article
Text
id pubmed-7967028
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-79670282021-03-18 Revisiting the Utility of Dilated Fundus Exams in Patients with Neovascular Age-Related Macular Degeneration Receiving Regular Intravitreal Injections Antaki, Fares Milad, Daniel Dirani, Ali Clin Ophthalmol Commentary Patients receiving regular anti-vascular endothelial growth factor (anti-VEGF) intravitreal injections for neovascular age-related macular degeneration (nAMD) routinely undergo dilated fundus examination (DFE) at each visit. In this paper, we review the current evidence on the utility of DFE in guiding treatment of established patients with nAMD and discuss novel treatment algorithms that defer DFE assessments with the advent of optical coherence tomography (OCT). We also debate on the value of DFE in the current sanitary context of COVID-19 and highlight important clinical scenarios where it must be performed. Dove 2021-03-12 /pmc/articles/PMC7967028/ /pubmed/33746511 http://dx.doi.org/10.2147/OPTH.S303551 Text en © 2021 Antaki et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Commentary
Antaki, Fares
Milad, Daniel
Dirani, Ali
Revisiting the Utility of Dilated Fundus Exams in Patients with Neovascular Age-Related Macular Degeneration Receiving Regular Intravitreal Injections
title Revisiting the Utility of Dilated Fundus Exams in Patients with Neovascular Age-Related Macular Degeneration Receiving Regular Intravitreal Injections
title_full Revisiting the Utility of Dilated Fundus Exams in Patients with Neovascular Age-Related Macular Degeneration Receiving Regular Intravitreal Injections
title_fullStr Revisiting the Utility of Dilated Fundus Exams in Patients with Neovascular Age-Related Macular Degeneration Receiving Regular Intravitreal Injections
title_full_unstemmed Revisiting the Utility of Dilated Fundus Exams in Patients with Neovascular Age-Related Macular Degeneration Receiving Regular Intravitreal Injections
title_short Revisiting the Utility of Dilated Fundus Exams in Patients with Neovascular Age-Related Macular Degeneration Receiving Regular Intravitreal Injections
title_sort revisiting the utility of dilated fundus exams in patients with neovascular age-related macular degeneration receiving regular intravitreal injections
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967028/
https://www.ncbi.nlm.nih.gov/pubmed/33746511
http://dx.doi.org/10.2147/OPTH.S303551
work_keys_str_mv AT antakifares revisitingtheutilityofdilatedfundusexamsinpatientswithneovascularagerelatedmaculardegenerationreceivingregularintravitrealinjections
AT miladdaniel revisitingtheutilityofdilatedfundusexamsinpatientswithneovascularagerelatedmaculardegenerationreceivingregularintravitrealinjections
AT diraniali revisitingtheutilityofdilatedfundusexamsinpatientswithneovascularagerelatedmaculardegenerationreceivingregularintravitrealinjections

Ejemplares similares